Trial intelligence / Profile preview

Comparative double-blind evaluation of local peri- and postoperative ropivacaine infiltration for pain management after hepatic surgery in adults

2007-007968-19Phase 3Completed

Sponsor
Centre Léon Bérard
Start
Apr 2008
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of ropivacaine (2 arms), sponsored by Centre Léon Bérard. Primary endpoint: Total morphine consumption per kilogram over 96 hours postoperatively. Started Apr 2008; status: completed.

02

Drugs

ropivacaine

Beyond the preview

Go deeper on 2007-007968-19.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-007968-19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call